Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor
Clinical trial NCT02842333 · COMPLETED
Trial details
- NCT number
- NCT02842333
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2020-10-06
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.